SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001607062-20-000327
Filing Date
2020-11-13
Accepted
2020-11-13 16:05:39
Documents
98
Period of Report
2020-07-31

Document Format Files

Seq Description Document Type Size
1 10-K gnbt073120form10k.htm 10-K 2962281
2 EXHIBIT 21 ex21.htm EX-21 16435
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 18464
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 18186
5 EXHIBIT 32 ex32.htm EX-32 7554
12 GRAPHIC image_001.jpg GRAPHIC 5829
  Complete submission text file 0001607062-20-000327.txt   9345935

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE gnbt-20200731.xml EX-101.INS 1386206
7 XBRL SCHEMA FILE gnbt-20200731.xsd EX-101.SCH 87622
8 XBRL CALCULATION FILE gnbt-20200731_cal.xml EX-101.CAL 79200
9 XBRL DEFINITION FILE gnbt-20200731_def.xml EX-101.DEF 378822
10 XBRL LABEL FILE gnbt-20200731_lab.xml EX-101.LAB 498828
11 XBRL PRESENTATION FILE gnbt-20200731_pre.xml EX-101.PRE 503668
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 000-25169 | Film No.: 201311472
SIC: 2834 Pharmaceutical Preparations